Nephros (NEPH) Free Cash Flow Growth (5y) (2015 - 2026)
Nephros (NEPH) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.11 Bn | 121.89 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.80 Bn | 43.99 Bn | 2.15 Bn |
| 3 | Alcon | 33.03 Bn | 31.37 Bn | 1.53 Bn |
| 4 | Medline | 32.85 Bn | 30.62 Bn | 1.84 Bn |
| 5 | Resmed | 29.39 Bn | 27.73 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.33 Bn | 22.89 Bn | 329.20 Mn |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.58% |
| Dec 31, 2025 | 16.23% |
| Sep 30, 2025 | 15.48% |
| Jun 30, 2025 | 20.85% |
| Mar 31, 2025 | 16.81% |
| Dec 31, 2024 | 29.07% |
| Sep 30, 2024 | -0.29% |
| Jun 30, 2024 | 17.73% |
| Mar 31, 2024 | 0.73% |
| Dec 31, 2023 | 12.36% |
| Sep 30, 2023 | 20.43% |
| Jun 30, 2023 | 16.74% |
| Mar 31, 2023 | 19.26% |
| Dec 31, 2022 | -16.09% |
| Sep 30, 2022 | 24.93% |
| Jun 30, 2022 | -18.68% |
| Mar 31, 2022 | -22.68% |
| Dec 31, 2021 | 8.70% |
| Sep 30, 2021 | -2.15% |
| Jun 30, 2021 | 14.16% |